The latest figures show that the SCS have now administered 2,150,326 doses of Covid vaccines in the Canary Islands, with 1,287,258 people who have received at least one dose which is 65.65% of the target population over 12 years old, or 68.80% of the target population over 16 years old.
In addition, up until yesterday 963,455 people are fully vaccinated against coronavirus, which represents 49.14% of the target population over 12 years of age in the Canary Islands.
The Ministry of Health is also appealing for residents over the age of 20 in Tenerife and Gran Canaria to register for their appointment as soon as possible, and anyone over 16 in Lanzarote, as they are aiming to have 70% of the target population fully immunized by the end of this month.
Many people are questioning as to why some groups are taking longer than others to fully vaccinate, for example, Groups 3 and 8, especially when one of these is people aged 60-65, yet group 10 (40-49 year olds) is already over 50% fully immunised.
The simple answer is the type of vaccine being used. Group 3 and 8 are both receiving the Astra Zeneca vaccine which had a delay after the first batch had been administered, and is 12 weeks between doses (compared to 3 weeks for Pfizer and 4 weeks for Moderna), and Group 10 are predominantly the Janssen single dose vaccine, so only one is necessary.
Group coverage so far:
In the latest revision of the National Vaccination Strategy, the following vaccination and prioritization groups are established:
Stage I:
Group 1: COMPLETE
Group 2: COMPLETE
Group 3: 100% one dose and 81.98% two doses. Non front-line health and social health personnel:
Group 4: 100% one dose and 77.86% two doses. Large household dependents.
Stage II:
Group 5: 100% one dose and 90.73% two doses. People aged over 60.
Group 5A: People aged 80 and over
Group 5B: People from 70 to 79 years old
Group 5C: People from 66 to 69 years old
Group 6: 92.43% one dose and 91.15% two doses. Groups with an essential function for society: police, army, emergency services, teachers.
Group 7: 100% one dose and 84.55% two doses. People under 60 years of age with severe Covid-19 high-risk conditions, ie health complications.
Group 8: 79.35% one dose and 50.41% two doses. People aged 60-65 years old.
Group 9: 88.25% one dose and 88.12% two doses. People aged 50-59 years old.
Group 10: 52.57% one dose and 51.65% two doses. People aged 40-49 years old.
Stage III:
Group 11: 46.34% with one dose and 10.02% with two doses. People between 30 and 39 years old.
Group 12: 16.00% with one dose. People between 20 and 29 years old.
Group 13: 4.12% with one dose. People between 12 and 19 years old.
